Go Pro

Aclarion (ACONW) Competitors

Aclarion logo
$0.03 0.00 (-3.58%)
Closing price 03:59 AM Eastern
Extended Trading
$0.03 0.00 (0.00%)
As of 03:59 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ACONW vs. DHACW, LFMDP, PIIIW, TALKW, and TOIIW

Should you buy Aclarion stock or one of its competitors? MarketBeat compares Aclarion with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aclarion include Digital Health Acquisition (DHACW), LifeMD (LFMDP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry.

How does Aclarion compare to Digital Health Acquisition?

Digital Health Acquisition (NASDAQ:DHACW) and Aclarion (NASDAQ:ACONW) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Aclarion N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Aclarion$77.88KN/AN/AN/AN/A

In the previous week, Aclarion had 2 more articles in the media than Digital Health Acquisition. MarketBeat recorded 2 mentions for Aclarion and 0 mentions for Digital Health Acquisition. Aclarion's average media sentiment score of 0.43 beat Digital Health Acquisition's score of 0.00 indicating that Aclarion is being referred to more favorably in the news media.

Company Overall Sentiment
Digital Health Acquisition Neutral
Aclarion Neutral

Summary

Aclarion beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does Aclarion compare to LifeMD?

Aclarion (NASDAQ:ACONW) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
LifeMD N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
LifeMD$193.33MN/AN/AN/AN/A

In the previous week, Aclarion and Aclarion both had 2 articles in the media. LifeMD's average media sentiment score of 0.96 beat Aclarion's score of 0.43 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
Aclarion Neutral
LifeMD Positive

Summary

LifeMD beats Aclarion on 2 of the 2 factors compared between the two stocks.

How does Aclarion compare to P3 Health Partners?

Aclarion (NASDAQ:ACONW) and P3 Health Partners (NASDAQ:PIIIW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends and profitability.

In the previous week, P3 Health Partners had 1 more articles in the media than Aclarion. MarketBeat recorded 3 mentions for P3 Health Partners and 2 mentions for Aclarion. Aclarion's average media sentiment score of 0.43 beat P3 Health Partners' score of 0.29 indicating that Aclarion is being referred to more favorably in the media.

Company Overall Sentiment
Aclarion Neutral
P3 Health Partners Neutral

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
P3 Health Partners N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$77.88KN/AN/AN/AN/A
P3 Health Partners$1.47BN/AN/AN/AN/A

Summary

P3 Health Partners beats Aclarion on 2 of the 3 factors compared between the two stocks.

How does Aclarion compare to Talkspace?

Talkspace (NASDAQ:TALKW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability.

Company Net Margins Return on Equity Return on Assets
TalkspaceN/A N/A N/A
Aclarion N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talkspace$238.37MN/AN/AN/AN/A
Aclarion$77.88KN/AN/AN/AN/A

In the previous week, Aclarion had 1 more articles in the media than Talkspace. MarketBeat recorded 2 mentions for Aclarion and 1 mentions for Talkspace. Talkspace's average media sentiment score of 1.89 beat Aclarion's score of 0.43 indicating that Talkspace is being referred to more favorably in the media.

Company Overall Sentiment
Talkspace Very Positive
Aclarion Neutral

Summary

Talkspace beats Aclarion on 2 of the 3 factors compared between the two stocks.

How does Aclarion compare to Oncology Institute?

Oncology Institute (NASDAQ:TOIIW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability, media sentiment and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$545.76MN/AN/AN/AN/A
Aclarion$77.88KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Oncology InstituteN/A N/A N/A
Aclarion N/A N/A N/A

In the previous week, Aclarion had 1 more articles in the media than Oncology Institute. MarketBeat recorded 2 mentions for Aclarion and 1 mentions for Oncology Institute. Oncology Institute's average media sentiment score of 1.87 beat Aclarion's score of 0.43 indicating that Oncology Institute is being referred to more favorably in the media.

Company Overall Sentiment
Oncology Institute Very Positive
Aclarion Neutral

Summary

Oncology Institute beats Aclarion on 2 of the 3 factors compared between the two stocks.

Get Aclarion News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACONW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACONW vs. The Competition

MetricAclarionHealth Information Services IndustryMedical SectorNASDAQ Exchange
Market CapN/A$333.66M$6.80B$12.48B
Dividend YieldN/A5.61%2.66%6.22%
P/E RatioN/A254.8425.7224.65
Price / SalesN/A136.26545.41102.66
Price / CashN/A47.1429.0936.93
Price / BookN/A7.6110.946.52
Net IncomeN/A-$22.78M$3.57B$336.61M
7 Day PerformanceN/A-0.03%2.21%1.24%
1 Month PerformanceN/A-0.37%0.55%0.28%
1 Year PerformanceN/A-9.86%36.44%30.62%

Aclarion Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACONW
Aclarion
N/A$0.03
-3.6%
N/A-27.1%$0.00$77.88KN/A7
DHACW
Digital Health Acquisition
N/A$0.04
flat
N/AN/A$0.00N/AN/AN/A
LFMDP
LifeMD
N/A$23.30
-0.9%
N/A-1.9%$0.00$193.33MN/A230
PIIIW
P3 Health Partners
N/A$0.01
-10.7%
N/A+31.1%$0.00$1.47BN/A500
TALKW
Talkspace
N/A$0.00
flat
N/AN/A$0.00$238.37MN/A500

Related Companies and Tools


This page (NASDAQ:ACONW) was last updated on 6/30/2026 by MarketBeat.com Staff.
From Our Partners